p53-Dependent DNA repair and apoptosis respond differently to high- and low-dose ultraviolet radiation

British Journal of Dermatology

Volumn 139, Issue 1, 1998, Pages 3-10

  Li, G ^a,b   Ho, V C ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b JACK BELL RESEARCH CENTRE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN BAX; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA REPAIR; EXCISION REPAIR; GENE EXPRESSION; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SKIN FIBROBLAST; STRESS; ULTRAVIOLET B RADIATION;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL CULTURE TECHNIQUES; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA; DNA REPAIR; DOSE-RESPONSE RELATIONSHIP, RADIATION; ENZYME INHIBITORS; FIBROBLASTS; GENES, P53; HUMANS; MICE; MICE, TRANSGENIC; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; RADIATION DOSAGE; TUMOR SUPPRESSOR PROTEIN P53; ULTRAVIOLET RAYS;

EID: 0031818021     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2133.1998.02305.x     Document Type: Article

References (43)

1. Kelfkens G, de Gruijil FR, van der Leun C. Ozone depletion and increase in annual carcinogenic ultraviolet dose. Photochem Photobiol 1990; 52: 254-7.
2. Yuspa SH, Dlugosz AA. Cutaneous carcinogenesis: natural and experimental. In: Physiology, Biochemistry, and Molecular Biology of the Skin (Goldsmith LA, ed.), 2nd edn. New York: Oxford University Press, 1991; 1365-402.
3. Alcalay J, Freeman SE, Goldberg LH, Wolf JE. Excision repair of pyrimidine dimers induced by simulated solar radiation in the skin of patients with basal cell carcinoma. J Invest Dermatol 1990; 95: 506-9.
4. Brash DE, Ziegler A, Jonason AS et al. Sunlight and sunburn in human skin cancer: p53, apoptosis, and tumor promotion. J Invest Dermatol Symp Proc 1996; 1: 136-42.
5. Brash DE, Rudolph JA, Simon JA et al. A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. Proc Natl Acad Sci USA 1991; 88: 10124-8.
6. Burns JE, Baird MC, Clark LJ et al. Gene mutations and increased levels of p53 protein in human squamous cell carcinomas and their cell lines. Br J Cancer 1993; 67: 1274-84.
7. Kanjilal S, Pierceall WE, Cummings KK et al. High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. Cancer Res 1993; 53: 2961-4.
8. Rady P, Scinicaiello F, Wagner RF Jr, Tyring SK. p53 mutations in basal cell carcinomas. Cancer Res 1992; 52: 3804-6.
9. Dumaz N, Drougard C, Sarasin A, Daya-Grosjean L. Specific UV-induced mutation spectrum in the p53 gene of skin tumors from DNA-repair-deficient xeroderma pigmentosum patients. Proc Natl Acad Sci USA 1993; 90: 10529-33.
10. Li G, Ho VC, Berean K, Tron VA. Ultraviolet radiation induction of squamous cell carcinomas in p53 transgenic mice. Cancer Res 1995; 55: 2070-4.
11. El-Deiry WS, Tokino T, Velculescu VE et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993; 75: 817-25.
12. Harper JW, Adami GR, Wei N et al. The p21 Cdk-interacting protein cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-16.
13. Xiong Y, Hannon GJ, Zhang H et al. p21 is a universal inhibitor of cyclin kinases. Science 1993; 366: 701-4.
14. Wang XW, Forrester K, Yeh H et al. Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 1994; 91: 2230-4.
15. Wang XW, Yeh H, Schaeffer L et al. p53 modulation of TFIIH-associated nucleotide excision repair activity. Nature Genet 1995; 10: 188-95.
16. Coverley D, Kenny MK, Lane DP, Wood RD. A role for the human single-stranded DNA binding protein HSSB/RPA in an early stage of nucleotide excision repair. Nucleic Acids Res 1992; 20: 3873-80.
17. Dutta A, Ruppert JM, Aster JC, Winchester E. Inhibition of DNA replication factor RPA by p53. Nature 1993; 365: 79-82.
18. Bakalkin G, Yakovleva T, Selivanova G et al. p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer. Proc Natl Acad Sci USA 1994; 91: 413-17.
19. Smith ML, Chen IT, Zhan Q et al. Involvement of the p53 tumor suppressor in repair of UV-type DNA. Oncogene 1995; 10: 1053-9.
20. Li G, Mitchell DL, Ho VC et al. Decreased DNA repair but normal apoptosis in ultraviolet-irradiated skin of p53-transgenic mice. Am J Pathol 1996; 148: 1113-23.
21. Li G, Ho VC, Mitchell DL et al. Differentiation-dependent p53 regulation of nucleotide excision repair in keratinocytes. Am J Pathol 1997; 150: 1457-64.
22. Clarke AR, Purdie CA, Harrison DJ et al. Thymocyte apoptosis induced by p53-dependent and independent pathways. Nature 1993; 362: 849-52.
23. Lowe SW, Schmitt EM, Smith SW et al. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 1993; 362: 847-9.
24. Lowe SW, Ruley HE, Jacks T, Housman DE. p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell 1993; 74: 957-67.
25. Lotem J, Sachs L. Hematopoietic cells from mice deficient in wild-type p53 are more resistent to induction of apoptosis by some agents. Blood 1993; 82: 1092-6.
26. Zhu YM, Bradbury DA, Russell NH. Wild-type p53 is required for apoptosis induced by growth factor deprivation in factor-dependent leukaemic cells. Br J Cancer 1994; 69: 468-72.
27. Symonds H, Krall L, Remington L et al. p53-dependent apoptosis suppresses tumor growth and progression in vivo. Cell 1994; 78: 703-11.
28. Ziegler A, Jonason AS, Leffell DJ et al. Sunburn and p53 in the onset of skin cancer. Nature 1994; 372: 773-6.
29. Reed JC. Bcl-2 and the regulation of programmed cell death. J Cell Biol 1994; 124: 1-6.
30. Oltvai ZN, Milliman CL, Korsmeyer SJ. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609-19.
31. Miyashita T, Reed JC. Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 1995: 80: 293-9.
32. Merchant AK, Loney TL, Maybaum J. Expression of wild-type p53 stimulates an increase in both Bax and Bcl-xL protein content in HT29 cells. Oncogene 1996; 13: 2631-7.
33. Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T. Bax suppresses tumorigenesis and stimulates apoptosis in vivo. Nature 1997; 385: 637-40.
34. Borner MM, Myers CE, Sartor O et al. Drug-induced apoptosis is not necessarily dependent on macromolecular synthesis or proliferation in the p53-negative human prostate cancer cell line PC-3. Cancer Res 1995; 55: 2122-8.
35. Skenhan P, Storeng R, Scudiero D et al. New colorimetric cytotoxicity assay for anticancer-drug screening. J Natl Cancer Inst 1990; 82: 1107-12.
36. Hall PA, McKee PH, Menage HD et al. High levels of p53 protein in UV-irradiated normal human skin. Oncogene 1993; 8: 203-7.
37. Lu X, Lane DP. Differential induction of transcriptionally active p53 following UV or ionizing radiation: defects in chromosome instability syndromes? Cell 1993; 75: 765-78.
38. Caelles C, Helmberg A, Karin M. p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature 1994; 370: 220-3.
39. Ford JM, Hanawalt PC. Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance. Proc Natl Acad Sci USA 1995; 92: 8876-80.
40. McKay BC, Francis MA, Rainbow AJ. Wild-type p53 is required for heat shock and ultraviolet light enhanced repair of a UV-damaged reporter gene. Carcinogenesis 1997; 18: 245-9.
41. McDonald ER III, Wu GS, Walman T, El-Deiry WS. Repair defect in p21 Waf1/Cip1 -/-human cancer cells. Cancer Res 1996; 56: 2250-5.
42. Pan ZQ, Reardon JT, Li L et al. Inhibition of nucleotide excision repair by the cyclin-dependent kinase inhibitor p21. J Biol Chem 1995; 270: 22008-16.
43. Cotton J, Spandau D. Ultraviolet B-radiation dose influences the induction of apoptosis and p53 in human keratinocytes. Radiat Res 1997; 147: 148-55.